人戊型肝炎病毒免疫可抵抗骆驼戊型肝炎病毒攻击
本研究先用静脉接种HEV-7建立恒河猴模型,再用HEV-1与HEV-3病毒样颗粒(VLP)肌注免疫恒河猴,免疫猴产生高滴度IgG抗体,完全抵抗HEV-7静脉攻击,提示VLP候选疫苗可用于预防HEV-7感染。
要点
- HEV-1与HEV-3 VLP免疫恒河猴后可完全抵抗HEV-7攻击。
- 免疫猴产生抗异源HEV-7的IgG抗体滴度高达>1:102,400。
- HEV-7感染恒河猴在实验中未显示肝损伤。
核心结论
- HEV-1和HEV-3 VLP免疫可完全保护恒河猴抵抗HEV-7静脉攻击。
研究设计与样本
- 研究先静脉接种HEV-7于恒河猴建立感染模型,再以HEV-1 VLP和HEV-3 VLP肌注免疫恒河猴并进行HEV-7攻击。
主要发现
- 免疫猴产生针对异源HEV-7的IgG抗体滴度高达>1:102,400且未使用佐剂。
- HEV-1 VLP和HEV-3 VLP免疫猴在HEV-7静脉攻击后完全免受感染。
- HEV-7感染的恒河猴在实验中未显示任何肝损伤。
临床怎么用
- HEV-1与HEV-3 VLP可作为预防HEV-7感染的候选疫苗。
局限性
- 仍需进一步努力建立动物模型以研究HEV-7感染所致戊型肝炎的发病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dromedary camel hepatitis E virus is a novel HEV that belongs to the family Hepeviridae, and is classified as genotype 7 HEV (HEV-7). Since HEV-7 is transmitted from camels to humans and causes acute hepatitis E, this virus is a non-negligible pathogen for zoonosis, and a vaccine against HEV-7 infection is urgently needed. Here, we first intravenously inoculated HEV-7 to rhesus monkeys to explore the susceptibility, and we established an animal model. We then used virus-like particles (VLPs) of HEV-1 (HEV-1 VLPs) and HEV-3 (HEV-3 VLPs), a candidate hepatitis E vaccine, to intramuscularly inoculate rhesus monkeys. The monkeys elicited IgG antibody titers as high as >1:102,400 against heterologous HEV-7 without any adjuvants. The HEV-1 VLPs and HEV-3 VLPs-immunized monkeys were challenged intravenously with HEV-7, and they were protected completely from the infection, demonstrating that these VLPs could be a usable vaccine against HEV-7 infection. We also observed that HEV-7-infected rhesus monkeys did not show any liver damage during these experiments. Further efforts are necessary to establish an animal model for investigation of the pathogenesis of hepatitis E caused by HEV-7 infection.
引用
- Guo Y, Yang F, Xu X, et al. Immunization of human hepatitis E viruses conferred protection against challenge by a camel hepatitis E virus. Vaccine. 2020. PMID: 32980200. doi:10.1016/j.vaccine.2020.09.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。